Specialisation in pharmacy - professional recognition in the European Union

Thursday 1 October 2015
D11, 3 hours

Organised by the FIP Clinical Biology Section, the FIP Hospital Pharmacy Section and the FIP SIG on Translational Research and Individualised Medicines


The European Directive 2005/36/EC on recognition of professional qualifications was an important step for the implementation of mutual recognition in-between European states. This mutual recognition allowed the automatic recognition of professions and was essential for the mobility of professionals that needed to practice outside their native countries. This system is based on harmonised minimum training requirements, recognition of evidence of training and professional experience. However, the mechanism of recognition defies the national professional organisations since different member states have different professional realities.

In end of 2013, this directive has been amended originating the 2013/55/EU directive. The purpose of this amendment was to review and correct certain points that originated difficulties to the professional mobility.

The specialisations in pharmacy are a real challenge to the different national bodies. Despite the attempt of harmonisation, there are very different scopes of the profession. Hospital pharmacy and Clinical Biology and Laboratory Medicine are specialisations in pharmacy that define this directive.  How can we face the future of these specialisations? How can we use this directive to facilitate this pharmacy professionals’ mobility?

Nevertheless, outside Europe we have a total different view and different ways of practice that should be investigated. The North America example is a good case-study to understand how these same pharmacies graduated professionals reach some specific specialised fields of practice and how these international differences can be so close together.       

Learning objectives

Knowledge-based session

At the conclusion of this session, participants will be able to:

  1. Identify the purposes of European Directives 2005/36/EC and 2013/55/EU.
  2. Define the importance of pharmacy specialisation and its impact on practice.
  3. Define the hospital pharmacy example and the directive implication on practice.
  4. Compare the clinical biology and laboratory medicine in Europe and the directive challenge on professional mobility.
  5. Identify how pharmacy graduates can specialise in different practice environments: clinical chemistry case-study.
  6. Understand the various pharmacy residency programmes available in the USA.

Chair: Sónia Faria (FIP CBS, Portugal) 


09:00 1) Challenges of hospital professional qualifications in Europe

Jacqueline Surugue (FIP HPS, France)

09:35 2) Laboratory medicine pharmacists in Europe

Simone Zarah (European Federation of Laboratory Medicine, France)

10:10 Break

10:30 3) Laboratory medicine in the USA 

Majid Moridani (Medical College of Wisconsin, USA)

11:05 4) Pharmacy residency programme in the USA

Lynn Crismon (The University of Texas at Austin, USA)

11:40 5) Open table discussion